Ann Arbor, MI, United States of America

Brennan Taylor Watch

This inventor holds 2 USPTO granted patents and 3 published patent applications. Top assignee: University of Michigan. Active years: 2022-2024.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Brennan Taylor Watch. Retrieved from https://idiyas.com/inventor/brennan-taylor-watch

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 2 

% Patents Active = 100.0

Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:


Years Active: 2022-2024

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Brennan Taylor Watch: Innovator in Cancer Treatment

Introduction

Brennan Taylor Watch is a notable inventor based in Ann Arbor, MI (US). He has made significant contributions to the field of cancer treatment through his innovative research and development. With a total of 2 patents, he is recognized for his work on compounds that modulate the epidermal growth factor receptor (EGFR).

Latest Patents

His latest patents include "EGFR dimer disruptors and use of the same." These patents provide compounds that modulate EGFR and methods of using them, particularly for treating cancer. This groundbreaking work has the potential to impact cancer therapies significantly.

Career Highlights

Brennan Taylor Watch is affiliated with the University of Michigan, where he conducts his research. His work is characterized by a commitment to advancing medical science and improving patient outcomes through innovative solutions.

Collaborations

Some of his notable coworkers include Mukesh K Nyati and Theodore S Lawrence. Their collaborative efforts contribute to the ongoing research and development in the field of cancer treatment.

Conclusion

Brennan Taylor Watch is a dedicated inventor whose work in cancer treatment through EGFR modulation showcases his innovative spirit and commitment to improving healthcare. His contributions are paving the way for future advancements in cancer therapies.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…